About the prevention of thromboembolic complications in neurosurgical patients
Almazov National Medical Research Centre
Neurosurgical patients are a separate specific group of patients to whom general recommendations for the prevention of thromboembolic complications cannot be applied. On the one hand, they have an increased risk of thrombus formation, on the other hand, a high risk of bleeding in the postoperative period. We divided all neurosurgical patients into two groups: the average risk of hemorrhagic complications - if necessary, and if hemostasis has taken place, it is possible to prescribe LMWH after 48-72 hours and a high-risk group, where the decision to carry out medical prophylaxis of venous thromboembolism has a personalized approach.
1) Christopher M. Loftus. Anticoagulation and Hemostasis in Neurosurgery. USA: Medicine Loyola University Maywood , IL; 2016.
2) Ulfsdotter Nilsson, Karin Strandberg, Martin Engström, Peter Reinstrup. Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. Perioper Med (Lond) 2016
3) A. Kotaska. Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines Thrombosis Journal, 2018
4) Rossiiskie klinicheskie rekomendacii po diagnostike, lecheniu i profilaktike venoznih tromboembolicheskih oslojnenii. Moskva; 2015.
5) Profilaktika venoznih tromboembolicheskih oslojnenii v travmatologii i ortopedii. Rossiiskie klinicheskie rekomendacii. Travmatologiya i ortopediya Rossii; 2012.
6) OST R 56377-2015 Gryppa R24 NACIONALNII STANDART ROSSIISKOI FEDERACII KLINIChESKIE REKOMENDACII (PROTOKOLI LEChENIYa); Rossiya, 2015.